SCHEMBL5520714

SCHEMBL5520714

C=CCN1CCN(c2cccc(C(=O)C(F)(F)F)c2C)CC1.COCCN1CCN(c2cccc(C(=O)C(F)(F)F)c2C)CC1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
DRD2 P14416 12/20 0.41
HTR2A P28223 8/20 0.41
HTR1A P08908 6/20 0.41
DRD3 P35462 6/20 0.40
DRD4 P21917 4/20 0.39
HTR2B P41595 2/20 0.39
HTR2C P28335 4/20 0.38
SLC6A4 P31645 3/20 0.38
DRD1 P21728 1/20 0.38
KCNH2 Q12809 1/20 0.38
ABCB1 P08183 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2782993 0.92 DRD2 (0.44) ALDH1A1DRD2HTR2AHTR1ADRD3
SCHEMBL2782426 0.91 GAA (0.41) KDM4EALDH1A1DRD2DRD3ABCB1
SCHEMBL5508720 0.90 DRD2 (0.45) KDM4EALDH1A1DRD2HTR2AHTR1A
SCHEMBL2784018 0.81 DRD2 (0.48) ALDH1A1DRD2HTR2AHTR1ADRD3
SCHEMBL2780681 0.81 ABCB1 (0.50) ALDH1A1DRD2HTR2AHTR1ADRD3
SCHEMBL2783579 0.80 DRD2 (0.51) DRD2HTR2AHTR1ADRD3DRD4
SCHEMBL2783650 0.80 DRD2 (0.48) ALDH1A1DRD2HTR2AHTR1ADRD3
SCHEMBL5505222 0.80 DRD2 (0.48) KDM4EALDH1A1DRD2HTR2AHTR1A
SCHEMBL2785169 0.79 TTR (0.41) KDM4EALDH1A1DRD2HTR1ADRD3
SCHEMBL2784881 0.78 ABCB1 (0.49) KDM4EALDH1A1DRD2DRD3ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773772-A1 NEW DISUBSTITUTED PHENYLPIPERIDINES/PIPERAZINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION A. CARLSSON RESEARCH AB (SE) 2007-04-18 EP claimed
WO-2005121087-A1 NEW DISUBSTITUTED PHENYLPIPERIDINES/PIPERAZINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION A. CARLSSON RESEARCH AB (SE) 2005-12-22 WO claimed